First Eagle Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,103
Closed -$203K 425
2024
Q3
$203K Sell
2,103
-1,431
-40% -$140K ﹤0.01% 376
2024
Q2
$324K Hold
3,534
﹤0.01% 372
2024
Q1
$326K Sell
3,534
-21,766
-86% -$2.04M ﹤0.01% 380
2023
Q4
$2.41M Sell
25,300
-46,876
-65% -$4.38M 0.01% 320
2023
Q3
$6.74M Sell
72,176
-3,430
-5% -$317K 0.02% 177
2023
Q2
$6.91M Sell
75,606
-25,775
-25% -$2.11M 0.02% 147
2023
Q1
$7.46M Buy
101,381
+42,413
+72% +$3.67M 0.02% 98
2022
Q4
$4.93M Buy
58,968
+30,917
+110% +$2.79M 0.01% 117
2022
Q3
$2.71M Buy
28,051
+3,011
+12% +$359K 0.01% 168
2022
Q2
$2.63M Buy
25,040
+24,915
+19,932% +$3.18M 0.01% 151
2022
Q1
$22K Buy
+125
New +$18.7K ﹤0.01% 361

Other funds holding AMED

First Eagle Investment Management's AMED Position: Q4 2024 in Review

First Eagle Investment Management sold out of Amedisys (AMED) in Q4 2024, closing a stake of 2,103 shares — an estimated $203K sold.

First Eagle Investment Management first reported a position in AMED in Q1 2022 and held it in 11 quarters. The position peaked at $7.46M in Q1 2023. 292 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • First Eagle Investment Management reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • First Eagle Investment Management sold 2,103 Amedisys shares in Q4 2024, an estimated $203K.
  • First Eagle Investment Management first reported a position in Amedisys in Q1 2022 and held it in 11 quarters.
  • First Eagle Investment Management's Amedisys position peaked at $7.46M in Q1 2023.
  • 292 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on First Eagle Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.